MedPath

Smartphone app for heart attack patients- A Clinical Trial

Not yet recruiting
Conditions
Chronic ischemic heart disease, unspecified,
Registration Number
CTRI/2021/12/038617
Lead Sponsor
JIPMER Alumni Association of North America
Brief Summary

This is a Digital health intervention randomized controlled trial  analyzing  an Android smartphone application for achieving risk factor modification and medication adherence in stable coronary artery disease patients for six months.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
178
Inclusion Criteria
  • Patients with clinically documented stable CAD attending cardiology OPD of JIPMER hospital.
  • 18 years to 64 years 3.
  • Able to use a smart phone with android function 4.
  • Able to read English or Tamil.
Exclusion Criteria
  • Recent ACS or PCI within 1 month 2.
  • Patients awaiting revascularization 3.
  • Has visual, auditory, cognitive or motor impairment 4.
  • COPD, Peripheral Vascular Disease, Post Pacemaker 6.
  • Recent CABG within 6 months.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Medication adherence will be measured by assessing the number of adherence failure events (defined as 1 missed dose during a observation cycle of 30 days) using pill counting method and Medication adherence score.Medication adherence will be measured by assessing the number of adherence failure events (defined as 1 missed dose during a observation cycle of 30 days) using pill counting method. | Improvement of CV risk factor targets (defined before).
Improvement of CV risk factor targets (defined before).Medication adherence will be measured by assessing the number of adherence failure events (defined as 1 missed dose during a observation cycle of 30 days) using pill counting method. | Improvement of CV risk factor targets (defined before).
Secondary Outcome Measures
NameTimeMethod
Change in Quality of Life, Stress level and Quality of sleep are the secondary outcomes measured at baseline, 12 weeks and 24 weeks3

Trial Locations

Locations (1)

Jawaharlal Institute of Postgraduate Medical Education and Research JIPMER

🇮🇳

Pondicherry, PONDICHERRY, India

Jawaharlal Institute of Postgraduate Medical Education and Research JIPMER
🇮🇳Pondicherry, PONDICHERRY, India
Dr Santhosh Satheesh
Principal investigator
9443426244
drsanthoshsatheesh@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.